GT Biopharma

-$0.84 (-5.29%) Today
+$0.05 (+0.33%) As of 8:14 PM UTC after-hours

Why Robinhood?

You can buy or sell GT Biopharma and other stocks, options, and ETFs commission-free!

About GTBP

GT Biopharma, Inc. Common Stock, also called GT Biopharma, is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform.

CEO
Anthony J. Cataldo
Employees
3
Headquarters
Beverly Hills, California
Founded
1965

GTBP Key Statistics

Market Cap
385.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
671.18K
High Today
$15.42
Low Today
$14.62
Open Price
$15.01
Volume
843.30K
52 Week High
$17.48
52 Week Low
$3.90

GTBP Earnings

-$3.40
-$2.27
-$1.13
$0.00
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 17, After Hours

You May Also Like

VST
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure